Down-regulation of PU.1 gene in our patients creates new insight into the importance of transcription regulation in the pathogenesis of ALL and introduces this gene as a probable molecular target in designing new treatment strategies. The gene discussed is SPI1; the disease is acute lymphoblastic leukemia.